Pipeline
| Modality | Program | Target | Indication | Hit Validation | Lead Optimization | Preclinical | Partner |
|---|---|---|---|---|---|---|---|
| SPiDEM™ | PRX302 | Tau | Alzheimer's Disease |
|
|||
| PRX303 | α-Synuclein | Parkinson's Disease |
|
||||
| PRX103 | BRD4 | Hematologic Cancers |
|
||||
| PRX403 | Undisclosed | Undisclosed (Oncology) |
|
 |
|||
| TBD | Undisclosed | Undisclosed (Oncology) |
|
 |
|||
| Small Molecule Inhibitor | PRX201 | p38 | Undisclosed |
|
|||
| PRX202 | NTCP | Chronic Hepatitis B |
|
||||